We are live on ! Find out more
DA

Dillon & Associates Portfolio holdings

AUM $726M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+0.03%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$156M
AUM Growth
Cap. Flow
+$159M
Cap. Flow %
101.76%
Top 10 Hldgs %
45.08%
Holding
61
New
61
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$9.5M
2
QCOM icon
Qualcomm
QCOM
+$8.04M
3
SYK icon
Stryker
SYK
+$7.92M
4
PEP icon
PepsiCo
PEP
+$7.63M
5
AAPL icon
Apple
AAPL
+$7.47M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Staples 23.06%
2 Technology 22.47%
3 Healthcare 20.19%
4 Industrials 11.78%
5 Consumer Discretionary 6.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVX icon
51
Chevron
CVX
$392B
$383K 0.25%
+3,245
New +$392K
AMGN icon
52
Amgen
AMGN
$208B
$381K 0.24%
+3,850
New +$400K
GPC icon
53
Genuine Parts
GPC
$17.1B
$363K 0.23%
+4,650
New +$361K
BHP icon
54
BHP
BHP
$215B
$326K 0.21%
+6,652
New +$369K
XRAY icon
55
Dentsply Sirona
XRAY
$2.68B
$256K 0.16%
+6,250
New +$261K
MDU icon
56
MDU Resources
MDU
$4.17B
$214K 0.14%
+21,694
New +$209K
SD
57
DELISTED
SANDRIDGE ENERGY, INC.
SD
$67K 0.04%
+13,302
New +$66.7K
RMTI icon
58
Rockwell Medical
RMTI
$28.4M
$41K 0.03%
+94
New +$39.8K
GCVRZ
59
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$21K 0.01%
+10,460
New +$18.4K
IMNN icon
60
Imunon
IMNN
$6.68M
$12K 0.01%
+1
New +$13.9K
ERN
61
DELISTED
Erin Energy Corp
ERN
$9K 0.01%
+6,085
New +$8.55K

Similar funds

Dillon & Associates's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Dillon & Associates, which disclosed 61 positions worth $156M. Its ten largest holdings account for 45% of the portfolio.

Its largest position is Colgate-Palmolive: 160,086 shares worth $9.13M.

By sector, the portfolio is most concentrated in Consumer Staples at 23% of assets, followed by Technology and Healthcare.

  • Dillon & Associates's largest Q2 2013 buy was Colgate-Palmolive: 160,086 shares worth $9.13M.
  • Dillon & Associates's ten largest holdings make up 45% of its $156M portfolio in Q2 2013.
  • Dillon & Associates disclosed 61 positions in Q2 2013, its first 13F filing on record.

Based on Dillon & Associates's 13F filing for Q2 2013, filed 9 Aug 2013.